Transaction in Own Shares

Summary by AI ^BETAClose X

London Stock Exchange Group PLC has completed its share buyback programme by purchasing 142,650 ordinary shares on April 8, 2026, through Morgan Stanley & Co. International Plc. The volume-weighted average price paid per share was 9,025.68p, with the highest price at 9,116.00p and the lowest at 8,908.00p. These repurchased shares will be cancelled, resulting in 496,683,821 ordinary shares in issue and 21,451,599 held in treasury, with total voting rights remaining at 496,683,821. This marks the final purchases under the irrevocable programme announced on February 26, 2026.

Disclaimer*

London Stock Exchange Group PLC

09 April 2026

London Stock Exchange Group PLC

TRANSACTIONS IN OWN SECURITIES

09 April 2026

London Stock Exchange Group plc (LSEG) announces today that it has purchased the following number of its ordinary shares of 6^79/86 pence each on the London Stock Exchange from Morgan Stanley & Co. International Plc (Morgan Stanley) as part of its share buyback programme, as announced on 26 February 2026:

Ordinary Shares

Date of purchase:	08 April 2026

Number of ordinary shares purchased:	142,650

Highest price paid per share:	9,116.00p

Lowest price paid per share:	8,908.00p

Volume weighted average price per share:	9,025.68p

LSEG intends to cancel all of the purchased shares.

Following the cancellation of the repurchased shares, LSEG has 496,683,821 ordinary shares of 6^79/86 pence each in issue (excluding treasury shares) and holds 21,451,599 of its ordinary shares of 6^79/86 pence each in treasury. Therefore, the total voting rights in the Company will be 496,683,821. This figure for the total number of voting rights may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Market Abuse Regulation (EU) No 596/2014 (as it forms part of the law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter) a full breakdown of the individual trades made by the Morgan Stanley on behalf of the Company as part of the buyback programme can be found at:

http://www.rns-pdf.londonstockexchange.com/rns/7077Z_1-2026-4-8.pdf

These purchases are the last purchases to be made under the irrevocable programme between LSEG and Morgan Stanley announced on 26 February 2026, and the programme has been completed in accordance with its terms.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

Contacts

Investors
Peregrine Riviere / Chris Turner - Investor Relations
ir@lseg.com

Media
Lucie Holloway / Rhiannon Davies - External Communications
+44 (0) 20 7797 1222
newsroom@lseg.com
www.lseg.com

Schedule of Purchases

Shares purchased:	142,650
Date of purchases:	08 April 2026
Investment firm:	Morgan Stanley & Co. International Plc

Aggregate Information:

Venue	Volume weighted average price	Aggregated Volume	Lowest price per share	Highest price per share
XLON	9,024.75p	121,875	8,908.00p	9,116.00p
TRQX	9,031.16p	20,775	8,908.00p	9,098.00p

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END